Aim: The prevalence of hyperuricemia has been increased in recent years. The metabolic syndrome (MS), which consists of multiple interrelated conditions, increases the risk for atherosclerosis, cardiovascular diseases and type 2 diabetes, as well as mortality from cardiovascular diseases and all causes [1] . Several studies have found an association between hyperuricemia and metabolic syndrome, moreover, several authors have suggested that serum uric acid (SUA) levels should be included in the definition of metabolic syndrome, as increased serum uric acid levels are independently associated with a higher risk of cardiovascular mortality. The aim of the present study was to analyze the association of hyperuricemia and metabolic syndrome and its several components in a Georgian population. The study includes 83 patients with MS and hyperuricemia (51 males and 32 females), aged 61±9 years, who have addressed to The First University Clinic of Tbilisi State Medical University from January 2017 to December 2017. All patients had asymptomatic hyperuricemia. 55 patients without MS constituted the control group. Biochemical parameters: glucose, Total-Cholesterol, HDL-cholesterol, LDL-cholesterol, Triglycerides, Creatinine, Uric acid, Creactive protein (CRP) were obtained with routine technique. Hyperuricemia was defined as SUA level ≥7.0 mg/dL in men and ≥6.0mg/dL in women. Waist circumference (cm) was measured and body mass index (BMI) was calculated (kg/m2). Results: The result of our study shows, that patients with MS show higher risk of hyperuricemia than those without MS -7.8 ±2.1 vs 5.9±1.3. Hyperuricemia was associated with a higher risk of presenting all the MS components, except hypertension and HDL. Conclusion: In the present study carried out in a Georgian population, we have found an association between SUA levels and MS, especially with Glucose intolerance, abdominal obesity and hypertriglyceridemia.
INTRODUCTION
The prevalence of hyperuricemia has been increased in recent years. The metabolic syndrome (MS), which consists of multiple interrelated conditions, increases the risk for atherosclerosis, cardiovascular diseases and type 2 diabetes, as well as mortality from cardiovascular diseases and all causes [1] . Several studies have found an association between hyperuricemia and metabolic syndrome, moreover, several authors have suggested that serum uric acid (SUA) levels should be included in the definition of metabolic syndrome, as increased serum uric acid levels are independently associated with a higher risk of cardiovascular mortality [2, 3, 4] . Although there are discrepancies as to which metabolic syndrome components play an importance role in this association. The aim of the present study was to analyze the association of hyperuricemia and metabolic syndrome and its several components in a Georgian population.
METHODS
The study include 83 patients with MS and hyperuricemia (51 males and 32 females) , aged 61±9 years, who have addressed to The First University Clinic of Tbilisi State Medical University from January 2017 to December 2017. All patients had asymptomatic hyperuricemia and patients under treatment with hypouricemic agents were excluded. 55 patients without MS constituted the control group. MS was defined according to the NCEP ATPIII criteria as having 3 or more risk factors: abdominal obesity (waist circumference ≥102 cm for men and ≥88cm for women); triglycerides ≥150mg/dL; HDL-C<40mg/dL for men and <50mg/dL for women; glucose ≥110mg/dL or a diagnosis of diabetes; blood pressure ≥130/≥85mmHg. Blood was collected after fasting for 12 hours. Biochemical parameters: glucose, TotalCholesterol, HDL-cholesterol, LDL-cholesterol, Triglycerides, Creatinine, Uric acid, C-reactive protein (CRP) were obtained with routine technique. Hyperuricemia was defined as SUA level ≥7.0 mg/dL in men and ≥6.0mg/dL in women. Waist circumference (cm) was measured and body mass index (BMI) was calculated (kg/m2). Data were expressed as mean±standard deviation (SD). For statistical inference, a p value of <0.05 was considered statistically significant.
RESULTS
The anthropometric and laboratory characteristics for MS patients and controls are shown in Table 1 . The mean age of the study sample was 61.4±9.2 years and control group 67.2±3.4. 51(61.4%) were male in MS group and 29(52.7%) in control group. MS patients presented higher BMI, waist circumference, glucose, SUA, creatinine, CRP, total-cholesterol and triglycerides. All 138 patients with MS we have divided into 2 groups: patients with SUA>6.5 mg/dL and < 6.5mg/dL (mean value for men and women) and have studied the frequency of components in patients ( Table  2 ). The frequency of MS, triglyceride, abdominal obesity and glucose intolerance was significantly higher in patients with SUA>6.5 mg/dL. 
DISCUSSION
There are several studies that have evaluated the association of hyperuricemia and MS in different population [5, 6, 7] . In a Korean population, Yoo et al. found that SUA independently correlated with all the MS components [8] . In a Taiwan study, Liu et al observed that the influence of hypertriglyceridemia was greater on SUA, followed by low HDL and Hypertension, but did not find an association with glucose intolerance or abdominal obesity [9] .
The result of our study shows, that patients with MS show higher risk of hyperuricemia than those without MS -7.8 ±2.1 vs 5.9±1.3. Hyperuricemia was associated with a higher risk of presenting all the MS components, except hypertension and HDL.
CONCLUSION
So, in the present study carried out in a Georgian population, we have found an association between SUA levels and MS, especially with Glucose intolerance, abdominal obesity and hypertriglyceridemia.
